AAIM
Asset Advisors Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,740
| Closed | -$643K | – | 97 |
|
|
2021
Q4 | $643K | Hold |
5,740
| – | – | 0.06% | 73 |
|
|
2021
Q3 | $722K | Hold |
5,740
| – | – | 0.08% | 70 |
|
|
2021
Q2 | $777K | Hold |
5,740
| – | – | 0.09% | 70 |
|
|
2021
Q1 | $744K | Hold |
5,740
| – | – | 0.09% | 72 |
|
|
2020
Q4 | $808K | Hold |
5,740
| – | – | 0.1% | 66 |
|
|
2020
Q3 | $640K | Hold |
5,740
| – | – | 0.1% | 66 |
|
|
2020
Q2 | $643K | Hold |
5,740
| – | – | 0.1% | 69 |
|
|
2020
Q1 | $445K | Sell |
5,740
-375
| -6% | -$29.1K | 0.08% | 80 |
|
|
2019
Q4 | $585K | Buy |
6,115
+225
| +4% | +$21.5K | 0.09% | 77 |
|
|
2019
Q3 | $449K | Sell |
5,890
-225
| -4% | -$17.2K | 0.07% | 79 |
|
|
2019
Q2 | $536K | Hold |
6,115
| – | – | 0.09% | 72 |
|
|
2019
Q1 | $554K | Hold |
6,115
| – | – | 0.1% | 73 |
|
|
2018
Q4 | $439K | Sell |
6,115
-100
| -2% | -$7.18K | 0.09% | 72 |
|
|
2018
Q3 | $596K | Buy |
+6,215
| New | +$596K | 0.1% | 77 |
|